v3.22.1
Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Revenues – Related Parties $ 888
Cost of revenues (657)
Gross profit 231
Research and development expenses, net (7,208) (7,205) (7,156)
General and administrative expenses (3,316) (3,500) (2,890)
Operating loss (10,293) (10,705) (10,046)
Financial income (expenses), net 73 (2) 14
Net loss $ (10,220) $ (10,707) $ (10,032)
Basic and diluted loss per ordinary share (in Dollars per share) $ (1.12) $ (1.17) $ (1.25)
Weighted average number of ordinary shares outstanding used in computing basic and diluted loss per ordinary share (in Shares) 9,148,143 9,136,600 8,038,140

Source